The majority of patients in CheckMate 204 had 1-2 metastatic lesions.
New answer by Radiation Oncologist at University of Arizona (August 2, 2025)
The results of CheckMate 204 showed that systemic therapy with both nivolumab and ipilimumab has clinically meaningful efficacy in patients with asymptomatic, untreated melano...